Table 2.

GH Research Society Consensus Guidelines [10]^*, criteria for investigations of the GH-IGF axis

Criteria
●	Severe short stature, height < -3 SDS
●	Height <1.5 SDS below midparental target height
●	Height < -2 SDS AND height velocity < -1 SDS for chronological age for >1 year; decrease in height SDS of >0.5 SDS over 1 year (children >2 years)
●	Height velocity < -2 SDS for >1 year, or height velocity < -1.5 SDS for 2 years
●	Signs indicative of an intracranial lesion
●	Signs of multiple pituitary hormone deficiency
●	Neonatal signs and symptoms of GH deficiency

^*endorsed by the Councils and Drug and Therapeutics Committees of the European Society for Pediatric Endocrinology and the (formerly Lawson Wilkins) Pediatric Endocrine Society, the Australasian Pediatric Endocrinology Group, the Japanese Society for Pediatric Endocrinology, and the Sociedad Latinoamericana de Endocrinologia Pediatrica.